PFG Advisors Buys 3,266 Shares of Danaher Corporation $DHR

PFG Advisors lifted its stake in Danaher Corporation (NYSE:DHR) by 9.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 38,754 shares of the conglomerate’s stock after purchasing an additional 3,266 shares during the period. PFG Advisors’ holdings in Danaher were worth $7,683,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. WFA of San Diego LLC bought a new position in Danaher in the second quarter worth about $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the second quarter worth about $27,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher during the 3rd quarter valued at approximately $27,000. TruNorth Capital Management LLC purchased a new position in shares of Danaher during the 3rd quarter worth approximately $28,000. Finally, Tripletail Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter worth approximately $31,000. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on DHR shares. HSBC raised their target price on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Morgan Stanley began coverage on Danaher in a research note on Monday, December 1st. They issued an “overweight” rating and a $270.00 price target on the stock. Evercore reiterated an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Wells Fargo & Company raised their price objective on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Finally, The Goldman Sachs Group reduced their target price on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $253.86.

Danaher Stock Performance

Shares of DHR opened at $195.60 on Monday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock has a market cap of $138.32 billion, a P/E ratio of 38.81, a P/E/G ratio of 2.64 and a beta of 0.93. The business’s 50 day moving average price is $222.53 and its 200-day moving average price is $215.99. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter last year, the company earned $2.14 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio is 25.40%.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. The trade was a 20.56% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 11.20% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.